{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "10923134", "DateCompleted": {"Year": "2000", "Month": "08", "Day": "22"}, "DateRevised": {"Year": "2022", "Month": "12", "Day": "07"}, "Article": {"ArticleDate": [], "Language": ["fre"], "ELocationID": [], "Journal": {"ISSN": "0755-4982", "JournalIssue": {"Volume": "29", "Issue": "23", "PubDate": {"Year": "2000", "Month": "Jul", "Day": "01"}}, "Title": "Presse medicale (Paris, France : 1983)", "ISOAbbreviation": "Presse Med"}, "ArticleTitle": "[St. Johns wort-venlafaxine interaction].", "Pagination": {"StartPage": "1285", "EndPage": "1286", "MedlinePgn": "1285-6"}, "AuthorList": [{"AffiliationInfo": [], "Identifier": [], "LastName": "Prost", "ForeName": "N", "Initials": "N"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Tichadou", "ForeName": "L", "Initials": "L"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Rodor", "ForeName": "F", "Initials": "F"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Nguyen", "ForeName": "N", "Initials": "N"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "David", "ForeName": "J M", "Initials": "JM"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Jean-Pastor", "ForeName": "M J", "Initials": "MJ"}], "PublicationTypeList": ["Case Reports", "Letter"], "VernacularTitle": "Interaction millepertuis-venlafaxine."}, "MedlineJournalInfo": {"Country": "France", "MedlineTA": "Presse Med", "NlmUniqueID": "8302490", "ISSNLinking": "0755-4982"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Cyclohexanols"}, {"RegistryNumber": "0", "NameOfSubstance": "Serotonin Uptake Inhibitors"}, {"RegistryNumber": "7D7RX5A8MO", "NameOfSubstance": "Venlafaxine Hydrochloride"}], "MeshHeadingList": [{"QualifierName": ["adverse effects", "pharmacology"], "DescriptorName": "Cyclohexanols"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Hypericum"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["chemically induced"], "DescriptorName": "Serotonin Syndrome"}, {"QualifierName": ["adverse effects", "pharmacology"], "DescriptorName": "Selective Serotonin Reuptake Inhibitors"}, {"QualifierName": [], "DescriptorName": "Venlafaxine Hydrochloride"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2000", "Month": "8", "Day": "3", "Hour": "11", "Minute": "0"}, {"Year": "2000", "Month": "8", "Day": "29", "Hour": "11", "Minute": "1"}, {"Year": "2000", "Month": "8", "Day": "3", "Hour": "11", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["10923134"]}}], "PubmedBookArticle": []}